News & Events
-
Congressional Testimony 2004
FDA Statements
-
November
- 11/18/2004
Ensuring the Safety, Effectiveness, and Availability of Influenza and Other Vaccines
Lester M. Crawford, D.V.M., Ph.D., before the House Committee on Energy and Commerce - 11/18/2004
Vioxx and Drug Safety
Sandra Kweder, M.D., before the Senate Committee on Finance - 11/17/2004
Ongoing Efforts to Ensure the Safety, Effectiveness, and Availability of Influenza and Other Vaccines
Lester M. Crawford, D.V.M., Ph.D., before the House Committee on Government Reform - 11/16/2004
Ensuring Safety, Effectiveness, and Availability of Influenza and Other Vaccines
Lester M. Crawford, D.V.M., Ph.D., before the Senate Special Committee on Aging
-
-
October
- 10/05/2004
Safety, Effectiveness, and Availability of Influenza and Other Vaccines
William Egan, Ph.D., before the House Committee on Appropriations, Subcommittee on Labor, Health and Human Services, Education and Related Agencies
-
-
September
- 09/23/2004
Anti-depressant Drug Use in Pediatric Populations
Robert Temple, M.D., before the House Committee on Energy and Commerce, Subcommitte on Oversight and Investigations - 09/08/2004
Pediatric Clinical Trials for Anti-depressant Drug Products
Janet Woodcock, M.D., before the House Committee on Energy and Commerce, Subcommittee on Oversight and Investigations - 09/08/2004
Vaccine Safety
William Egan, Ph.D., before the House Committee on Government Reform, Subcommittee on Human Rights and Wellness
-
-
July
- 07/22/2004
Importation of Prescription Drugs
John M. Taylor, III, before the Senate Committee on Governmental Affairs, Permanent Subcommittee on Investigations - 07/14/2004
Importation of Prescription Drugs
William K. Hubbard, before the Senate Committee on the Judiciary
-
-
June
- 06/25/2004
Implementation of the Food Security Provisions of the Public Health Security and Bioterrorism Preparedness and Response Act
Lester M. Crawford, D.V.M., Ph.D., before the House Committee on Energy and Commerce, Subcommittee on Health - 06/23/2004
The Law of Biologic Medicine
Lester M. Crawford, D.V.M., Ph.D., before the Senate Committee on the Judiciary - 06/08/2004
Dietary Supplement Safety Act: How is FDA Doing 10 Years Later
Robert E. Brackett, Ph.D., before the Senate Committee on Governmental Affairs, Subcommittee on Oversight of Government Management, The Federal Workforce, and the District of Columbia - 06/03/2004
Combating the Nation’s Obesity Epidemic
Lester M. Crawford, D.V.M., Ph.D., before the House Committee on Governmental Reform - 06/03/2004
Combating the Obesity Epidemic
Lynn C. Swann, before the House of Government Reform
-
-
May
- 05/20/2004
Imported Drugs
John M. Taylor, III, before the Senate Committee on Health, Education, Labor and Pensions - 05/18/2004
Conflict of Interest
Emanuel F. Petricoin III, Ph.D., before the House Committee on Energy and Commerce, Subcommittee on Investigation and Oversight - 05/18/2004
Comments on Ethics
Statement for the Record, before the House Committee on Energy and Commerce, Subcommittee on Oversight and Investigations - 05/18/2004
Regulation of Medical Devices
Steven Gutman, M.D., before the House Committee on Government Reform, Subcommittee on Criminal Justice, Drug Policy and Human Resources - 05/13/2004
Accelerating Innovative Cancer Treatments
Richard Pazdur, M.D., before the House Committee on Government Reform
-
-
April
- 04/27/2004
Importation of Pharmaceutical Products
William K. Hubbard, before the Senate Committee on Finance, Subcommittee on Healthcare and Subcommittee on International Trade - 04/01/2004
Potential Merits of Cannabinoids for Medical Uses
Robert J. Meyer, M.D., before the House Committee on Government Reform, Subcommittee on Criminal Justice, Drug Policy, and Human Resources
-
-
March
- 03/30/2004
Potential Benefits of a Single Food Agency
Robert E. Brackett, Ph.D., before the House Committee on Government Reform, Subcommittee on Civil Service and Agency Organization - 03/24/2004
The Status of Dietary Supplements in the United States
Robert E. Brackett, Ph.D., before the House Committee on Government Reform, Subcommittee on Human Rights and Wellness - 03/18/2004
Internet Drug Sales
William K. Hubbard, before the House Committee on Government Reform - 03/11/2004
Labeling of Condoms
Daniel G. Schultz, M.D., before the House Committee on Government Reform, Subcommittee on Criminal Justice, Drug Policy, and Human Resources - 03/11/2004
Cost of Prescription Drugs
Mark B. McClellan, M.D., before the Senate Committee on Commerce, Science and Transportation
-
-
February
- 02/09/2004
Preventing Prescription Drug Abuse
Robert J. Meyer, M.D., before the House Committee on Government Reform, Subcommittee on Criminal Justice, Drug Policy, and Human Resources
-
-
January
- 01/27/2004
Bovine Spongiform Encephalopathy (BSE)
Lester M. Crawford, D.V.M., Ph.D., before the Senate Committee on Agriculture, Nutrition, and Forestry
-
-
-